Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2020 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers.
Marx A, Schumann A, Höflmayer D, Bady E, Hube-Magg C, Möller K, Tsourlakis MC, Steurer S, Büscheck F, Eichenauer T, Clauditz TS, Graefen M, Simon R, Sauter G, Izbicki JR, Huland H, Heinzer H, Haese A, Schlomm T, Bernreuther C, Lebok P, Polonski A. Marx A, et al. Among authors: bady e. Sci Rep. 2020 Jun 2;10(1):8916. doi: 10.1038/s41598-020-65772-w. Sci Rep. 2020. PMID: 32488048 Free PMC article.
Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence.
Dum D, Henke TLC, Mandelkow T, Yang C, Bady E, Raedler JB, Simon R, Sauter G, Lennartz M, Büscheck F, Luebke AM, Menz A, Hinsch A, Höflmayer D, Weidemann S, Fraune C, Möller K, Lebok P, Uhlig R, Bernreuther C, Jacobsen F, Clauditz TS, Wilczak W, Minner S, Burandt E, Steurer S, Blessin NC. Dum D, et al. Among authors: bady e. Lab Invest. 2022 Jan 29. doi: 10.1038/s41374-022-00728-4. Online ahead of print. Lab Invest. 2022. PMID: 35091676
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.
Freytag M, Kluth M, Bady E, Hube-Magg C, Makrypidi-Fraune G, Heinzer H, Höflmayer D, Weidemann S, Uhlig R, Huland H, Graefen M, Bernreuther C, Wittmer C, Tsourlakis MC, Minner S, Dum D, Hinsch A, Luebke AM, Simon R, Sauter G, Schlomm T, Möller K. Freytag M, et al. Among authors: bady e. BMC Cancer. 2020 Dec 18;20(1):1220. doi: 10.1186/s12885-020-07682-8. BMC Cancer. 2020. PMID: 33339518 Free PMC article.